Literature DB >> 23158633

Vasculitis and panniculitis associated with vemurafenib.

Roberto A Novoa, Kord Honda, Henry B Koon, Meg R Gerstenblith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23158633     DOI： 10.1016/j.jaad.2012.05.019

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

Review 1.  Managing the skin toxicities from new melanoma drugs.

Authors:  John C Mavropoulos; Timothy S Wang
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 2.  Systemic vasculitis associated with vemurafenib treatment: Case report and literature review.

Authors:  Adrien Mirouse; Léa Savey; Fanny Domont; Cloé Comarmond; Stéphane Barete; Emmanuelle Plaisier; Philippe Rouvier; Patrice Cacoub; David Saadoun
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

3.  Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect.

Authors:  Miruna Negulescu; Florian Deilhes; Vincent Sibaud; Emilie Tournier; Laurence Lamant; Serge Boulinguez; Nicolas Meyer
Journal:  Case Rep Dermatol       Date:  2017-03-21

4.  Delayed-onset vemurafenib-induced panniculitis.

Authors:  Stephen L Vance; Hannah M Singer; David Silvers; Sameera Husain; Filamer Kabigting
Journal:  JAAD Case Rep       Date:  2017-08-30

Review 5.  Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.

Authors:  Lucie Heinzerling; Thomas K Eigentler; Michael Fluck; Jessica C Hassel; Daniela Heller-Schenck; Jan Leipe; Matthias Pauschinger; Arndt Vogel; Lisa Zimmer; Ralf Gutzmer
Journal:  ESMO Open       Date:  2019-05-23

6.  Scurvy in a patient on vemurafenib.

Authors:  Meg R Gerstenblith; Tatyana A Petukhova; Henry B Koon
Journal:  JAAD Case Rep       Date:  2014-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.